Best Genomics Companies in Georgia, United States
The 37 best Genomics companies in Georgia, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Arunabio.
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Georgia
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Arunabio Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases 42Funding top 29%Talent bottom 49%Market bottom 47%Global bottom 37% All 5 signals ▾Fundingtop 29% Talentbottom 49% Marketbottom 47% Globalbottom 37% Newsbottom 18% Funding: Raised $33.1M across 20 rounds · 20 rounds over 9 yrs (2.2/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 42/100 | $33M | 13 mo ago | Series B | Steven Stice Co-Founder Chief Scientific Officer | 2003 | — | — | — |
| 2 | Axion Biosystems Develops multi-electrode array technology to provide access to cellular information analysis | $20M | 80 mo ago | Acquired | — | 2007 | DrupalMariaDBPHP+24 | 43 patents Integrated electrophysiology‑optogenetics microelectrode arrays for high‑throughput cell culture assays | 1 launch |
| 3 | GuideTX Providing technology for DNA and RNA delivery system | $14M | 73 mo ago | Acquired | James Dahlman Co-Founder | 2019 | — | — | — |
| 4 | Expression Therapeutics Provider of gene therapy technology for the treatment of hemophilia A | $13M | 19 mo ago | Funding Raised | — | 2005 | — | — | — |
| 5 | GQ Life Sciences Online search tools for life science research | $11M | 201 mo ago | Acquired | — | 2001 | — | 8,014 patents Integrated biomedical wearables, advanced drug delivery systems, and high-throughput biotech manufacturing | — |
| 6 | Phigenix Pharmaceuticals Personalized medicine company developing cancer diagnostics and targeted therapies | $5M | 132 mo ago | Series A | — | 2007 | — | — | — |
| 7 | AKESOgen Provider of research services for scientists doing clinical and basic research | $2M | 89 mo ago | Seed | Robert Boisjoli Co-Founder & CEO | 2010 | — | — | 1 launch |
| 8 | Jeevan Biosciences Developer of human in vitro cell models for preclinical drug development in cancer | $767K | 181 mo ago | Deadpooled | — | 2007 | — | — | — |
| 9 | BiotecEra Synthetic biology for production of industrially valuable chemicals | $450K | 128 mo ago | Funding Raised | Yuheng Lin Co-Founder & CTO | 2014 | — | — | — |
| 10 | Sequegenics Provider of solutions for analyzing complex genetic datasets | $251K | 61 mo ago | Funding Raised | Jorge Eloy Alan Atala Founder & Cto | 2017 | — | — | — |
| 11 | Otogenetics Provider of the next-generation sequencing platform for genetic testing | $229K | 204 mo ago | Funding Raised | Aloma Geer CEO & MD | 2007 | WordPressApple iCloud MailGoogle Workspace+13 | — | — |
Top 12 Genomics companies in Georgia
#1
Series B · Athens, Georgia · founded 2003 · 40 employees$33.1Mraised▾
Developer of a neural exosome platform to design therapeutics for the treatment of neurodegenerative diseases. The platform develops neural exosomes to cross the blood-brain barrier and enhance the body's anti-inflammatory, self-repair, and protective mechanisms to treat a range of neurodegenerative disorders. The lead candidate drug AB126 is developed to treat stroke, Parkinson's, and multiple sclerosis
- Aug 2025Grant (prize money)$400K
- Jun 2022Grant (prize money)$679.4K
- Apr 2021Series B$10.8M
- Sep 2019Grant (prize money)$4.5M
#2
Funding Raised · Tucker, Georgia · founded 2005 · 21 employees$12.6Mraised▾
Provider of gene therapy technology for the treatment of hemophilia A. The company is developing a high expression factor VIII technology that substantially decreases the cost of manufacturing factor VIII. The gene therapy is based on Lentivirus and AAV, and a bioengineered factor VIII transgene. The company's therapeutic pipeline includes novel gene therapies for hemophilia A, hemophagocytic lymphohistiocytosis (HLH), neuroblastoma, leukemia/lymphoma.
- Jan 2025Grant (prize money)$388.2K
- Sep 2023Grant (prize money)$388.2K
- May 2019Grant (prize money)$225K
- Feb 2017Grant (prize money)$225K
#3
Acquired · Atlanta, Georgia · founded 2007 · 14 employees$20.3Mraised▾
Axion BioSystems develops multi-electrode array technology to provide access to cellular information analysis for research, clinical, and drug discovery markets. It offers single-well systems, stimulating and recording channels, channel systems, multi-well systems, and integrated circuits for the elimination of stimulation artifacts.
- Jan 2020Grant (prize money)$2.8M
- Sep 2018Series C$8M
- May 2016Series C$6M
- Apr 2016Grant (prize money)$220K
#4
Acquired · Tucker, Georgia · founded 2019$13.9Mraised▾
GuideTx provides technology for DNA and RNA delivery to the target. It is involved in developing nucleic acid-based drugs for treating the diseases specifically and cure it at the genetic level. The company offers its flagship lipid nanoparticle (LNP), which is used to deliver RNA to hepatocytes and also FDA approved. It also offers its drug proprietary screening platform and helps in developing nanoparticles carrying DNA or RNA i.e. nucleic acid drug which can be functionally delivered into the cytoplasm or nucleus.
- Aug 2020Series A$5.9M
- Jan 2020Series A$8M
- Apr 2019Series A$6M
- Mar 2019Series A—
#5
Acquired · Alpharetta, Georgia · founded 2001 · 16 employees$11.2Mraised▾
GQ Life Sciences (formerly GenomeQuest) is a developer of life science research-based search tools. Its products include LifeQuest (a patent search platform based on semantic and life science ontology keywords) and GenomeQuest (a database of DNA, RNA, and protein sequences collected, indexed, and curated from patent records in public and proprietary databases).
- Dec 2009Series A$3.1M
- Sep 2007Series A$4M
- Nov 2005Series A$4.1M
#6
Series A · Atlanta, Georgia · founded 2007 · 5 employees$4.6Mraised▾
Personalized medicine company developing cancer diagnostics and targeted therapies. They pioneer new approaches in early cancer detection and targeted inhibition of cancer oncogenes. They are developing diagnostic tests to identify cancer patients likely to benefit from specific therapies and are creating a cancer vaccine that utilizes mRNA to selectively target cancer cells for immune system destruction. They focus on companion diagnostics and targeted therapies, developing diagnostic tests for pre-malignant state detection and therapeutics that block the expression of cancer-causing proteins. They are a leader in the rapidly evolving cancer diagnostic and therapeutics industry, utilizing patents and pending patents to develop state-of-the-art technology in cancer personalized medicine.
- Aug 2015Series A$842.4K
- Jul 2014Series A$3.7M
#7
Seed · Norcross, Georgia · founded 2010 · 1526 employees$1.5Mraised▾
Provider of research services for scientists doing clinical and basic research. It provides biomarker profiling, cytogenomic arrays, sequencing (NGS and Sanger), genotyping, and epigenomic by analyzing different types of markers (like DNA, mRNA, miRNA, and methylation) and biobanking. It is certified by CLIA and CAP.
- Apr 2019Seed$1.5M
#8
Deadpooled · Atlanta, Georgia · founded 2007 · 9 employees$767.2Kraised▾
Developer of human in vitro cell models for preclinical drug development in cancer. The company's platform is claimed to do the following; (i) provide pure human cancer stem cell models that accurately represent cancer tissue, (ii) provide a media that allows human cell tissue to be cultured in an environment free of animal and other non-human products, and (iii) identify unique biomarkers in cancer stem cells that can be accurately and consistently targeted by a drug delivery platform.
- Aug 2011Grant (prize money)$383.6K
- Jul 2011Grant (prize money)$383.6K
#9
Funding Raised · Atlanta, Georgia · founded 2017 · 4 employees$251.1Kraised▾
Provider of solutions for analyzing complex genetic datasets. It is a cloud-based platform integrates various pipelines, allowing users to navigate and explore the genetic makeup of patients. It helps to detect and identify structural variants, INDELs, copy number variants, and other mutant genes in genomic data. It also, offers Genome sequencing-based device for self blood collection.
- Aug 2021Grant (prize money)$251.1K
#10
Funding Raised · Athens, Georgia · founded 2014$450Kraised▾
BiotecEra is a biotechnology company dedicated to development and commercialization of innovative microbial technologies for the production of industrially valuable chemicals. The company specializes in the development of powerful industrial microbes using the principles of microbiology, metabolic engineering, and protein engineering. The company's current portfolio includes the engineered microbes for the production of 5-hydroxytryptophan, 4-hydroxycoumarin and the bio-based manufacturing of a biodegradable polymer.
- Jan 2016Grant (prize money)$225K
- Jul 2015Grant (prize money)$225K
#11
Funding Raised · Atlanta, Georgia · founded 2007 · 21 employees$229.4Kraised▾
Provider of the next-generation sequencing platform for genetic testing. The company offers services such as human, mouse exome sequencing, RNA sequencing, mitochondrial genome sequencing, disease panels for breast cancer genes, cardiomyopathy, colorectal cancer, etc. It also provides disease panel services (clinical) for breast cancer, deafness, inherited cancer. Also, it offers products and reagents such as DNA Library, preparation kits, whole mitochondrial DNA NGS Deep sequencing kits, and more
- Sep 2009Grant (prize money)$229.4K
#12
Acquired · Atlanta, Georgia · founded 2001 · 11 employees—raised▾
Provider of sequencing services for diagnostics and research. The service portfolio of the company includes RNA Sequencing, MNG Exome, Repeat Expansion Fragile X, Repeat Expansion through clinical services, complex biochemical testing, and other sequencing services sequencing.
- Apr 2015Series A—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Georgia is moving
A read on the academic research around Bioinformatics in Georgia — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 161 papers.
- Georgia Institute of Technology88
- University of Georgia40
- Georgia State University19
- Georgia Southern University4
- Georgia College & State University3
- Gene1→7
- Genome3→5
- Gene2→3
- Immune system1→4
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.